Singapore markets close in 48 minutes
Straits Times Index
3,297.85 +25.13 (+0.77%) Nikkei
38,460.08 +907.92 (+2.42%) Hang Seng
17,171.26 +342.33 (+2.03%) FTSE 100
8,081.17 +36.36 (+0.45%) Bitcoin USD
66,638.67 +458.05 (+0.69%) CMC Crypto 200
1,436.47 +12.37 (+0.87%)
SELLAS Life Sciences Group, Inc. (SLS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 91.72M |
| Enterprise value | 90.09M |
| Trailing P/E | 0.61 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 26.90 |
| Price/book (mrq) | 5.90 |
| Enterprise value/revenue | 20.84 |
| Enterprise value/EBITDA | -2.38 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.37 |
| 52-week change 3 | 11.64% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 1.9100 |
| 52-week low 3 | 0.5000 |
| 50-day moving average 3 | 1.1568 |
| 200-day moving average 3 | 1.1796 |
Share statistics
| Avg vol (3-month) 3 | 1.46M |
| Avg vol (10-day) 3 | 1.21M |
| Shares outstanding 5 | 56.27M |
| Implied shares outstanding 6 | 56.27M |
| Float 8 | 55.63M |
| % held by insiders 1 | 0.50% |
| % held by institutions 1 | 10.47% |
| Shares short (28 Mar 2024) 4 | 5.27M |
| Short ratio (28 Mar 2024) 4 | 3.01 |
| Short % of float (28 Mar 2024) 4 | 9.38% |
| Short % of shares outstanding (28 Mar 2024) 4 | 9.37% |
| Shares short (prior month 29 Feb 2024) 4 | 4.51M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 08 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:50 |
| Last split date 3 | 08 Nov 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -174.27% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -37.34M |
| Diluted EPS (ttm) | -1.3400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.53M |
| Total cash per share (mrq) | 0.05 |
| Total debt (mrq) | 906k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.23 |
| Book value per share (mrq) | -0.25 |
Cash flow statement
| Operating cash flow (ttm) | -31.41M |
| Levered free cash flow (ttm) | -29.64M |
© 2024 Yahoo. All rights reserved.